Their half-lives are 13 hours (LIRA) and 7 days (SEMA), allowing for daily and weekly subcutaneous administration, respectively, thanks to the structural modifications introduced.5,10 Effects on obesity and glycaemic control Both LIRA 3 mg and SEMA 2.4 mg have demonstrated a strong appetite-suppressing and satiety-promoting effect, as well as a delaying effect on gastric emptying.11,12 The SCALE programme highlighted the efficacy of LIRA 3 mg in reducing body weight and waist circumference13 and confirmed a reduction in HbA1c levels in individuals with diabetes, along with a decreased progression from prediabetes to diabetes after three years of treatment14 (Table 1)
The good news is that the results seen by people who take this product have been quite impressive
In some cases, medications for anxiety or depression may be offered to help cope with the emotional toll
By sustaining mitochondrial function, the peptide appears to reduce free radical formation
Alcohol and your gut: why it matters more during midlife Your gut is one of the most important organs for processing both alcohol and histamine, and perimenopause puts it under additional strain